These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 22920872)
1. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?]. Asnafi V; Ferrier P Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872 [No Abstract] [Full Text] [Related]
2. TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression. Dadi S; Le Noir S; Payet-Bornet D; Lhermitte L; Zacarias-Cabeza J; Bergeron J; Villarèse P; Vachez E; Dik WA; Millien C; Radford I; Verhoeyen E; Cosset FL; Petit A; Ifrah N; Dombret H; Hermine O; Spicuglia S; Langerak AW; Macintyre EA; Nadel B; Ferrier P; Asnafi V Cancer Cell; 2012 Apr; 21(4):563-76. PubMed ID: 22516263 [TBL] [Abstract][Full Text] [Related]
3. TLX1-induced T-cell acute lymphoblastic leukemia. De Keersmaecker K; Ferrando AA Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452 [TBL] [Abstract][Full Text] [Related]
4. Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice. Shields BJ; Alserihi R; Nasa C; Bogue C; Alexander WS; McCormack MP Leukemia; 2015 Apr; 29(4):927-38. PubMed ID: 25283843 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia. Durinck K; Van Loocke W; Van der Meulen J; Van de Walle I; Ongenaert M; Rondou P; Wallaert A; de Bock CE; Van Roy N; Poppe B; Cools J; Soulier J; Taghon T; Speleman F; Van Vlierberghe P Leukemia; 2015 Dec; 29(12):2317-27. PubMed ID: 26108691 [TBL] [Abstract][Full Text] [Related]
6. Notch in T-ALL: new players in a complex disease. Koch U; Radtke F Trends Immunol; 2011 Sep; 32(9):434-42. PubMed ID: 21775206 [TBL] [Abstract][Full Text] [Related]
7. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. McCormack MP; Young LF; Vasudevan S; de Graaf CA; Codrington R; Rabbitts TH; Jane SM; Curtis DJ Science; 2010 Feb; 327(5967):879-83. PubMed ID: 20093438 [TBL] [Abstract][Full Text] [Related]
8. [Demonstration of leukemic stem cells in the human T-ALLs and study of the involvement of the NOTCH, TAL1 and ERK/MAPK pathways in human T-leukemogenesis]. Gerby B; Armstrong F; Brunet de la Grange P; Calvo J; Ballerini P; Pflumio F Ann Pathol; 2008 Nov; 28 Spec No 1(1):S28-9. PubMed ID: 18984291 [No Abstract] [Full Text] [Related]
10. The Ets-1 transcription factor is required for complete pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus. Eyquem S; Chemin K; Fasseu M; Bories JC Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15712-7. PubMed ID: 15496469 [TBL] [Abstract][Full Text] [Related]
11. MEIS proteins as partners of the TLX1/HOX11 oncoprotein. Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479 [TBL] [Abstract][Full Text] [Related]
12. T lymphocyte development in p56lck deficient mice: allelic exclusion of the TcR beta locus is incomplete but thymocyte development is not restored by TcR beta or TcR alpha beta transgenes. Wallace VA; Kawai K; Levelt CN; Kishihara K; Molina T; Timms E; Pircher H; Penninger J; Ohashi PS; Eichmann K Eur J Immunol; 1995 May; 25(5):1312-8. PubMed ID: 7774634 [TBL] [Abstract][Full Text] [Related]
13. Expression of ets genes in mouse thymocyte subsets and T cells. Bhat NK; Komschlies KL; Fujiwara S; Fisher RJ; Mathieson BJ; Gregorio TA; Young HA; Kasik JW; Ozato K; Papas TS J Immunol; 1989 Jan; 142(2):672-8. PubMed ID: 2536061 [TBL] [Abstract][Full Text] [Related]
14. At the crossroads: diverse roles of early thymocyte transcriptional regulators. Anderson MK Immunol Rev; 2006 Feb; 209():191-211. PubMed ID: 16448544 [TBL] [Abstract][Full Text] [Related]
15. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Muthusamy N; Barton K; Leiden JM Nature; 1995 Oct; 377(6550):639-42. PubMed ID: 7566177 [TBL] [Abstract][Full Text] [Related]
16. Novel insights into the development of T-cell acute lymphoblastic leukemia. Staal FJ; van Dongen JJ; Langerak AW Curr Hematol Malig Rep; 2007 Jul; 2(3):176-82. PubMed ID: 20425367 [TBL] [Abstract][Full Text] [Related]
18. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3. Su X; Drabkin H; Clappier E; Morgado E; Busson M; Romana S; Soulier J; Berger R; Bernard OA; Lavau C Genes Chromosomes Cancer; 2006 Sep; 45(9):846-55. PubMed ID: 16804919 [TBL] [Abstract][Full Text] [Related]
19. TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia. Tan SH; Yam AW; Lawton LN; Wong RW; Young RA; Look AT; Sanda T Leukemia; 2016 Apr; 30(4):959-62. PubMed ID: 26202930 [No Abstract] [Full Text] [Related]
20. The TLX1 oncogene drives aneuploidy in T cell transformation. De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]